DAPD COMBINATION THERAPY WITH INOSINE MONOPHOSPHATE DEHYDROGENASE INHIBITOR

• 1. 用肌苷一磷酸脱氢酶抑制剂进行的DAPD联合治疗 [P] . 中国专利： CN1501828A . 2004-06-02
• 2. 用于治疗多囊肾的雷帕霉素衍生物或肌苷－5′－单磷酸脱氢酶抑制剂 [P] . 中国专利： CN101300008A . 2008-11-05
• 3. DAPD combination therapy with inosine monophosphate dehydrogenase inhibitor. [P] . OA12588A . 2006-06-08

  机译： DAPD与肌苷单磷酸脱氢酶抑制剂联合治疗。

• 4. Dapd combination therapy with inosine monophosphate dehydrogenase inhibitor [P] . BR0116223A . 2006-01-31

  机译： 肌苷单磷酸脱氢酶抑制剂的联合治疗

• 5. DAPD COMBINATION THERAPY WITH INOSINE MONOPHOSPHATE DEHYDROGENASE INHIBITOR. [P] . MXPA03005382A . 2005-02-03

  机译： DAPD联合肌苷磷酸肌苷脱氢酶抑制剂的联合治疗。

• 1. Calcium channel blocker monotherapy versus combination with renin-angiotensin system inhibitors on the development of new-onset diabetes mellitus in hypertensive Korean patients [J] . Yong Hoon Kim, Woohyeun Kim, Woong Gil Choi, 老年心脏病学杂志（英文版） . 2019,第006期
• 2. Combination therapy in cancer：effects of angiogenesis inhibitors on drug pharmacokinetics and pharmacodynamics [J] . Ilaria Fuso Nerini, Marta Cesca, Francesca Bizzaro, 癌症（英文版） . 2016,第012期
• 3. C-Nucleoside Analogs of Tiazofurin and Selenazofurin as Inosine 5'-Monophosphate Dehydrogenase Inhibitors [C] . P. Franchetti, L. Cappellacci, M. Grifantini, Symposium on Inosine Monophosphate Dehydrogenase: A Major Therapeutic Target null null . 2000
• 4. Design, synthesis and biological evaluation of human inosine 5'-monophosphate dehydrogenase inhibitors: 1,5-diazabicyclo(3.1.0)hexane-2,4-diones, as novel isozyme-selective cancer chemotherapeutic agents. [D] . Barnes, Betsy Jo. 1999
• 5. In Vitro Combination of Amdoxovir and the Inosine Monophosphate Dehydrogenase Inhibitors Mycophenolic Acid and Ribavirin Demonstrates Potent Activity against Wild-Type and Drug-Resistant Variants of Human Immunodeficiency Virus Type 1 [O] . Katyna Borroto-Esoda, Florence Myrick, Joy Feng, 2004
• 6. In Vitro Combination of Amdoxovir and the Inosine Monophosphate Dehydrogenase Inhibitors Mycophenolic Acid and Ribavirin Demonstrates Potent Activity against Wild-Type and Drug-Resistant Variants of Human Immunodeficiency Virus Type 1 [O] . Borroto-Esoda, Katyna, Myrick, Florence, Feng, Joy, 2004

• 1. Association of adverse effects with monoamine oxidase type B inhibitor and catechol-o-methyl transferase inhibitor combination therapy in Parkinson’s disease patients [J] . Rui Zhang ,Danielle C. Spengler ,Marie-Helene Saint-Hilaire . 帕金森（英文） . 2012,第1期
• 2. Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer [J] . Shih-Hung Yang ,Ting-Chun Kuo ,Hsu Wu . 世界胃肠病学杂志：英文版 . 2016,第32期
• 3. Perioperative Use of Methotrexate and Tumor Necrosis Factor α Inhibitors Combination Therapy Is Not Likely to Increase Post-Operative Infection Rate in the National Veterans Health Administration Administrative Databases [J] . Hsin-Hsuan Juo ,Anders Peck ,Sarah E. Monsell . 风湿病与自身免疫疾病期刊（英文） . 2019,第1期
• 4. 去羟肌苷散、司他夫定和奈韦拉平联合治疗HIV-1感染初步观察 [C] . 胡越凯 ,卢洪洲 ,薛以乐 . 第五届全国感染性疾病及抗微生物化疗学术会议 . 2003
• 5. 稻瘟病菌鸟苷酸激酶MoGuk1及肌苷-5’-磷酸乳酸脱氢酶MoImd4活性位点的生物学功能研究 [A] . 蔡兴嘉 . 2016